GW003
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GW003, covering 2016-02-24 to 2017-08-18. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer [Phase 1]